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Abstract
Background: Diabetes mellitus is a metabolic disorder of epidemic proportion, projected to become the major
cause of morbidity and mortality in the world in future. Despite extensive research in understanding this disease at
molecular level, and the discovery of new drugs, diabetes and its complications remain largely untreated. Many of
the late diabetic complications are associated with the glycation of proteins in the body. Natural flora has long
been a rich source for therapeutic agents, especially against diabetes. The present study deals with the anti-
glycation properties of some medicinally important plants of Arabian region.
Methods: Twenty-six medicinal plants, commonly found in different regions of Arabian Peninsula, were evaluated
for their protein anti-glycation activity by using BSA-MG glycation assay in-vitro. The extracts were incubated with
BSA and MG at 37 °C for 9 days, each sample was then examined for the presence of fluorescence (λex 330 nm,
and λem 420 nm), which represent the extent of protein glycation. Antioxidant activity was evaluated by using 1,1-
diphenyl- 2-picrylhydrazyl (DPPH), iron chelation, and superoxide radical scavenging asaays.
Results: The data revealed that out of 26 medicinal plants, five plants viz. Sida cordifolia, Plumbago zeylanica, Tribulus
terrestris, Glycyrrhiza glabra, and Rosa indica were active against the in-vitro protein glycation with IC50 values between
0.408- 1.690 mg/mL. Among the active plants, Glycyrrhiza glabra L. was found to be the most potent (IC50 = 0.408 ± 0.
027 mg/mL), followed by Rosa indica (IC50 = 0.596 ± 0.0179 mg/mL), and Sida cordifolia L. (IC50 = 0.63 ± 0.009 mg/mL).
The antioxidant potential of these plant extracts were also determined by using DPPH (2,2-diphenyl-1-picrylhydrazyl),
iron chelation, and superoxide anion radical scavenging assays. Among five plants, Sida cordifolia exhibited a potent
anti-oxidant activity in both DPPH and superoxide anion radical scavenging assays (IC50 = 0.005 ± 0.0004, and 0.078 ± 0.
002 mg/mL, respectively), followed by Rosa indica (IC50 = 0.023 ± 0.0005 and 0.141 ± 0.003 mg/mL, respectively).
Conclusions: Protein glycation in hyperglycemic conditions involve oxidative changes. Therefore dual inhibition of
protein glycation and oxidation are desirable properties in any test substance investigated for therapeutic purposes.
Keywords: Arabian medicinal plants, Diabetes, Advanced glycation end products (AGEs), Antioxidant, Glycyrrhiza glabra
L., Rosa indica L., Sida cordifolia L.
Background
Diabetes mellitus (DM) is an impending public health
challenge of the present century [1]. It affects over 387
million people globally, and this number is projected to
increase to 592 million by 2035. DM is currently the
fourth leading cause of mortality in the world. It has
also emerged as a major socioeconomic burden for
developing countries [2]. In last three decades, exten-
sive research has been conducted on glycation and
anti-glycation processes in diabetes, based on the fact
that the hyperglycemic condition or excess glucose in
blood leads to the binding of free sugars with bio-
molecules [3–5]. Glycation is a spontaneous, non-
enzymatic reaction between biomolecules (proteins,
lipids, and DNA) and reducing sugars (such as glucose,
fructose, and ribose), resulting in the formation of ad-
vanced glycation endproducts (AGEs) [6–8]. The acceler-
ated process of proteins glycation has been identified as a
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marker, as well as a core reason for the onset of many dia-
betic complications, affecting the eyes, blood vessels, kid-
neys, skin, etc. [9, 10]. Oxidative reactions are known to
be involved in the protein glycation cascade. Most import-
antly, AGEs, via their receptors (RAGEs), inactivate the
enzymes and promote the formation of reactive oxygen
species (ROS). It is suggested that the generation of oxy-
gen free radicals by glycation of biomolecules is one of the
major biochemical pathways of oxidative tissue damage in
diabetes. Search for agents with dual inhibitory effects, i.e.
antioxidant and anti-glycation, is therefore a valid ap-
proach towards the treatment of complications resulting
from non-enzymatic glycation reaction [11, 12]. Although
extensive research has been conducted on various classes
of glycation inhibitors, but none has reached to the clin-
ical use. Therefore, there is an urgent need to identify the
agents which inhibit or reverse the complex reactions of
protein glycation, and oxidation.
Evidences about the anti-diabetic properties of medi-
cinal plants have been continuously reported. During the
last two decades, we have been focusing on bioactive
natural products. This has led to the identification of
several classes of safe and effective lead molecules [12–
16]. Information on dual inhibition pattern (anti-glyca-
tion and antioxidant activity) of traditional Arabian me-
dicinal plants is scarce. So far no large-scale systematic
study of the anti-glycation activity of medicinal herbs
has been conducted. Therefore, the present study was
designed to identify new and effective inhibitors of pro-
tein glycation during hyperglycemia from medicinal
plants of Arabian region. We evaluated 26 medicinal
plants, commonly found in different regions of Arabian
Peninsula. These plants are used in herbal medicines for
the treatment of different diseases, including diabetes.
Methods
Chemicals
Bovine serum albumin (BSA), and ethanol was purchased
from Merck Marker Pvt. Ltd. (Germany), methylglyoxal
(MG) (40 % aqueous solution), 2,2-diphenyl-1-picrylhydrazyl
(DPPH), iron chloride, ferrozine, β-nicotanamide adenine di-
nucleotide (NADH), nitro blue tetrazolium (NBT), phena-
zine methosulphate (PMS), Quercetin (purity: ≥95.0 %),
Gallic acid (purity: ≥98.0 %), and rutin (purity: ≥90 %) were
from Sigma Aldrich (Japan). Sodium azide (NaN3),
disodium hydrogen phosphate (Na2HPO4), and sodium
dihydrogen phosphate (NaH2PO4) were obtained from
Scharlau Chemie, S. A. (Spain), while dimethyl sulphoxide
(DMSO) was acquired from Fischer Scientific (UK).
Plant material
All plant samples were collected from different regions
of Arabian Peninsula. Different parts of these plants
(such as leaves, flowers, stems, or roots; Table 1) were
separately processed for the preparation of crude ex-
tracts. Plants were identified by taxonomist at the De-
partment of Botany, University of Karachi, Karachi,
Pakistan (Herbarium voucher numbers are mentioned
in supporting information). The samples were air-dried,
protecting from sunlight, and powdered. These powdered
samples were then stored at room temperature.
Preparation of the crude extracts of medicinally
important plants
Crude extracts were prepared by extracting different
powdered parts of the plants (1 Kg) in 3 L distilled
methanol. In brief, the extracts were obtained by triple
soaking in methanol for 3 days (at room temperature)
and the solvent was evaporated under reduced pressure.
The crude extracts were then freeze dried, and the ex-
tracts were solublized in DMSO and used for the in-vitro
experiments.
In-vitro anti-glycation assay
The reaction was performed in triplicate, and in such a
way that in 200 μL solution, the final concentration of
BSA was 10 mg/mL, methylglyoxal was 14 mM, and test
extracts (dissolved in DMSO; final concentration 10 %)
were 2 mg/mL. Solution of methylglyoxal and BSA were
prepared in phosphate buffer (0.1 M, pH 7.4, containing
3 mM sodium azide as antimicrobial agent). Briefly, the
200 μL of reaction mixture comprised of BSA (50 μL),
methylglyoxal (50 μL), test extracts (20 μL), and phos-
phate buffer (80 μL), while in the negative control wells,
20 μL of DMSO (final concentration 10 %) was added
instead of test extracts. It was then incubated at 37 °C
for 9 days (under sterile conditions). After incubation,
each sample was examined for the development of fluor-
escence (λex 330 nm and λem 420 nm), against blank on
a microtitre plate reader (SpectraMax M5, Molecular
Devices, CA, USA) [17]. Rutin was used as positive con-
trol. The percent inhibition of each extract was calcu-
lated by using the following formula:
% Inhibition
¼ 1− Fluorescence of test sample= Fluorescence of the controlð Þ
 100
In-vitro antioxidant activities
DPPH Free radical scavenging assay
Solution of DPPH (0.3 mM) was prepared in ethanol,
while different concentrations of the test extracts were
prepared in DMSO. In each well of 96-wells plate, 5 μL
of the test extracts and 95 μL of DPPH solution were
added, and the pre-read (absorbance) was recorded at
515 nm. The reaction was then incubated for 30 min at
37 °C. Plate was shaken for 1 min for thorough mixing
and the change in absorbance was recorded at 515 nm
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on microplate-reader (SpectraMax M5, Molecular De-
vices, CA, USA) [18]. Gallic acid was used as a positive
control. The percentage of DPPH radical scavenging was
calculated by using following formula:
% RSA ¼ 100− ΔA Sample =ΔA Controlð Þ x100
(Where RSA = radical scavenging activity and ΔA =
change in absorbance)
Iron chelation assay
The Fe2+-chelating ability was determined according to
the method of Koncic et al. with slight modifications
[19]. In this assay, the concentration of Fe2+ ion was
measured through the formation of ferrous ion–ferro-
zine complex. Plant extracts, dissolved in DMSO (2 mg/
mL, 5 μL), was mixed with 0.3 mM FeCl2 (35 μL) and
0.5 mM ferrozine (60 μL). Ferrozine reacted with the di-
valent iron resulting in the formation of stable violet col-
ored complex (soluble in water). The mixture was
shaken and left at room temperature for 10 min. The
change in the absorbance of the resulting mixture was
measured at 562 nm by using SpectraMax M5 (Molecu-
lar Devices, CA, USA). Disodium EDTA was used as a
reference compound.
Superoxide anion radical scavenging assay
The reaction mixture contained 10 μL of crude plant
extracts (2 mg/mL; dissolved in DMSO), 90 μL of phos-
phate buffer (0.1 M; pH 7.4), 40 μL of (0.2 mM) β-nico-
tanamide adenine dinucleotide (NADH), and 40 μL of
(0.081 mM) nitro blue tetrazolium (NBT). The reaction
was initiated by the addition of 20 μL of (0.008 mM)
phenazine methosulphate (PMS). The solutions of
NADH, NBT and PMS were prepared in phosphate
buffer (0.1 M; pH 7.4) [20]. The formation of super-
oxide was monitored by measuring the absorbance of
the blue formazan dye after 5 min at 560 nm by using
microtitre plate reader (SpectraMax M5, Molecular
Devices, CA, USA). Quercetin was used as a positive
control.
Statistical analysis
The results were analyzed by using SoftMax Pro Soft-
ware (Molecular Devices, CA, USA), and expressed as
the mean ± S.E.M. of three experiments. The IC50 values
were calculated by the EZ-Fit enzyme kinetics program
(Perellela Scientific, Inc., Amherst, Mars, USA). Graph-
Pad Prism 5, program was used for plotting dose de-
pendant graphs of active plant extracts and for other
graphs.
Results
Results revealed that out of 26 medicinal plants, five
plants (i.e. Sida cordifolia, Plumbago zeylanica, Tribu-
lus terrestris, Glycyrrhiza glabra, and Rosa indica)
were able to inhibit the in-vitro protein glycation with
IC50 values between 0.408- 1.690 mg/mL, while
remaining plant extracts were found to be inactive as
they showed less than 50 % inhibition at 2 mg/mL
concentration (Table 1). Among five active plants,
Glycyrrhiza glabra L. was found to be the most po-
tent (IC50 = 0.408 ± 0.027 mg/mL; Fig. 1), followed by
Rosa indica (IC50 = 0.596 ± 0.0179 mg/mL; Fig. 2) and
Sida cordifolia L. (IC50 = 0.63 ± 0.009 mg/mL; Fig. 3).
Extract of Plumbago zeylanica and Tribulus terrestris
showed a week anti-glycation potential (IC50 = 1.300 ±
0.033 and 1.690 ± 0.020 mg/mL, respectively), as com-
pared to other active plants in this study (Table 1;
Figs. 4 and 5).
The plants which were found to be active against pro-
tein glycation in-vitro (i.e. Sida cordifolia, Plumbago
zeylanica, Tribulus terrestris, Glycyrrhiza glabra, and
Rosa indica) were evaluated for DPPH radical scaven-
ging activity. Figure 6 shows that all plants were active
(Table 2; Fig. 6). Gallic acid was used as positive control
in this assay. Results revealed that Sida cordifolia L.
showed a potent antioxidant activity when compared
with remaining four active plants.
In the next stage, five active plants (i.e. Sida cordifolia,
Plumbago zeylanica, Tribulus terrestris, Glycyrrhiza gla-
bra, and Rosa indica) were evaluated for iron chelating
ability. Table 2 showed that none of these has the ability
to chelate with the iron at 2 mg/mL concentration. In
the final step of this study, selected plants were evalu-
ated for superoxide anion radical scavenging activity.
Results showed that, except G. glabra, all other plants
were found to scavenge the superoxide anion radicals
effectively (Table 2, Figs. 7, 8, 9 and 10).
Discussion
The present study was carried out to study medicinal
plants of Arabian origin as anti-glycation agents. In this
study, we systematically evaluated 26 medicinal plants
for their anti-glycation activity potential (Table 1). Re-
sults revealed that out of 26 medicinal plants, five (i.e.
Sida cordifolia, Plumbago zeylanica, Tribulus terrestris,
Glycyrrhiza glabra, and Rosa indica) were found active
against the in-vitro protein glycation. Among five active
plants, Glycyrrhiza glabra L. (Voucher number: 37999)
was found to be the most potent one. G. glabra belongs
to the Fabaceae/Leguminosae family. It is famous for
underground stems, which is widely used in flavor con-
fectionery [21]. This plant is also known for its diverse
biological activities, such as anti-inflammatory, anti-
microbial, hepatoprotective properties. It is also used as
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Table 1 Anti-glycation activity of extracts of medicinally important plants of Arabian origin






1. Abrus precatorius L. Fabaceae Jequirity or Crab's eye Fruits 5.03 NA2
2. Acacia concinna (Willd.) DC. Fabaceae Soap-nut acacia Fruits −2.14 NA2
3. Azadirachta indica A. Juss. Meliaceae Indian-lilac Fruits 18.02 NA2
4. Balsamodendron mukul Hook. Burseraceae Indian bdellium Gum −8.24 NA2
5. Calotropis procera
(Aiton) W. T. Aito.
Apocynaceae Sodom apple Flowers 5.70 NA2
6. Cassia senna Linn. Caesalpiniaceae Senna Leaves 42.89 NA2
7. Chenopodium album L. Amaranthaceae Lamb's quarters Whole plant 9.68 NA2
8. Citrullus colocynthis (L.) Schrad. Cucurbitaceae Bitter apple Fruits −1.87 NA2
9. Daucus carota L. Apiaceae Wild carrot Seeds 13.26 NA2
10. Glycyrrhiza glabra L. Fabaceae Licorice/ Liquorice Roots 81.20 0.408 ± 0.027
11. Guilandina moringa L. Moringaceae Moringa Leaves −29.72 NA2
12. Gymnema sylvestre R. Br. Apocynaceae Miracle fruit Leaves 39.28 NA2
13. Hedysarum alhagi L. Fabaceae Camelthorn Fruit peel 8.80 NA2
14. Lactuca sativa L. Asteraceae Lettuce Seeds 34.51 NA2
15. Plumbago zeylanica L. Plumbaginaceae Ceylon leadwort or Doctor bush Branches 64.53 1.300 ± 0.033
16. Punica granatum L. Lythraceae Pomegranate Flowers 0.293 NA2
17. Rhus coriaria L. Anacardiaceae Sumac Seeds 33.55 NA2
18. Rosa indica L. Rosaceae Cyme rose Flowers 78.56 0.596 ± 0.0179
19. Sesamum indicum L. Pedaliaceae Sesame Seeds −103.80 NA2
20. Sida cordifolia L. Malvaceae Country-mallow Seeds 81.98 0.63 ± 0.009
21. Tamarindus indica L. Fabaceae Tamrhindi Fruits −3.85 NA2
22. Tephrosia purpurea (L.) Pers. Fabaceae Purple tephrosia Branches 33.26 NA2
23. Trianthema pentandra var. flava Blatt & Halb. Aizoaceae Trianthema Roots 33.08 NA2
24. Tribulus terrestris L. Zygophyllaceae Devil's thorn Seeds 56.67 1.690 ± 0.020
25. Vitis vinifera L. Vitaceae Wild grape Fruits 2.14 NA2
26. Zizyphus vulgaris Lam. Rhamnaceae Chinese date Fruits 0.286 NA2
27. Rutin3 – – – 95.56 0.196
1IC50 Values are presented in mg/mL ± standard error of mean of three assays;
2NA: Not Active; 3Standard inhibitor for anti-glycation assay




















Fig. 1 In-vitro anti-glycation activity of methanolic extract of Glycyrrhiza glabra
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folk remedy for sore throats, mouth ulcers, stomach ul-
cers, inflammatory stomach conditions, and indigestion
[22–26]. G. glabra was also reported for hypoglycemic
activity in rats [27]. G. glabra- based herbal formulations
are known to exhibit anti-AGEs activities. Additionally a
pure substance (glycyrrhizic acid) from the roots of this
plant showed anti-glycation potential in high fat diet
treated rats [14, 28, 29]. Major constituents of G. glabra
include flavonoids, isoflavonoids, saponins, and tripen-
tenes [30]. Literature has no report describing the in-
vitro anti-glycation activity of root extracts of G. glabra.
In our study methanolic extracts of G. glabra showed
63.42 % inhibition (IC50 = 0.408 ± 0.027 mg/mL) in BSA-
MG glycation assay (Table 1; Fig. 1). Therefore in view
of these results, G. glabra may be used as a therapeutic
agent to reduce AGEs formation in diabetes.
Rosa indica L. (Voucher number: 91863) is an orna-
mental plant, known for perfuming effect. It possess
pharmacological properties such as antioxidant, anti-
fungal, anti-bacterial and urease inhibitory activities
[31–33]. Manikandan et al. reported the synthesis of
silver nanoparticles using extract of the petals of Rosa
indica (ethanolic extract), and its in-vitro antibacterial, an-
ticancer and anti-inflammatory activities. Different parts
of R. indica (e.g. petals and buds) are known to treat runny
nose, blocked bronchial tubes, asthma, and chest prob-
lems [34]. The bioactive compounds isolated, from Rosa
indica, include flavonoids, alkaloids, phenols, saponins,
and steroids [35]. There is no report describing the anti-
glycation activity of R. indica. In our in-vitro experimental
assay, R. indica showed a good anti-glycation potential
with 78.56 % inhibition (IC50 = 0.596 ± 0.0179 mg/mL)
(Table 1; Fig. 2).
The third most potent plant Sida cordifolia L. (Vou-
cher number: 12135) belongs to Malvaceae family. Roots
of S. cordifolia are used in coryza, pain, cardiac diseases,
nervous disorders, and for anti-inflammatory, analgesic,
hypoglycemic, antimicrobial, anti-hypercholesterolemic,




















Fig. 2 In-vitro anti-glycation activity of methanolic extract of Rosa indica






















Fig. 3 In-vitro anti-glycation activity of methanolic extract of Sida cordifolia
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antioxidant activities [36–40]. In addition, the extract
of S. cordifolia has shown the anti-aging properties
[41]. Major phytoconstituents of Sida cordifolia include
alkaloids, flavonoids, steroids, phytoecdysteroids, and
fatty acids [42]. As per literature survey, this is the first re-
port describing the anti-glycation potential of the metha-
nolic extracts of the seeds of S. cordifolia. In the present
study, S. cordifolia showed 81.98 % inhibition of BSA-MG
glycation with IC50 = 0.63 ± 0.009 mg/mL (Table 1; Fig. 3).
Crude extract of Plumbago zeylanica L. (voucher No.
24177) and Tribulus terrestris L. (voucher No. 53177)
showed a week anti-glycation potential (IC50 = 1.300 ±
0.033, and 1.690 ± 0.020 mg/mL, respectively), when
compared with the other active plants of this study
(Table 1; Fig. 4 and 5).
The plant P. zeylanica showed many biological proper-
ties, such as anti-inflammatory, hypolipidimic, wound heal-
ing, antidiabetic, memory-inducing, blood coagulation,
anti-malarial, anti-fertility, anti-microbial, anticancer,
antiviral, antioxidant, and anti-larvicidal activities. The
phytochemical investigation showed that these bio-
logical activities are due to the presence of compounds,
such as elliptinone, zeylanone, sistosterol and plumbagin
[43]. Tribulus terrestris L. is known for several pharmaco-
logical properties, and its use in folk medicine for the
treatment of impotence, edema, rheumatism, kidney
stones, and hypertension. T. terrestris contains phenols,
saponins, alkaloids and sterols as active constituents [44].
Oxidative reactions are known to be involved in the
protein glycation cascade. Most importantly, AGEs via
their receptors (RAGEs), inactivate the enzymes and
promote the formation of reactive oxygen species. Dual
activity, i.e. antioxidant and anti-glycation, is therefore a
valid approach for the treatment of complications result-
ing from hyperglycemia [11, 12]. The antioxidant activ-
ities of plants are mainly due to two mechanisms, i.e.
scavenging the free radicals produced in the body or by
chelating the transition metal [45]. Keeping this in view,
all active plants (i.e. Sida cordifolia, Plumbago zeylanica,
Tribulus terrestris, Glycyrrhiza glabra, and Rosa indica)






















Fig. 4 In-vitro anti-glycation activity of methanolic extract of Plumbago zeylanica














Fig. 5 In-vitro anti-glycation activity of methanolic extract of Tribulus terrestris
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were evaluated for their DPPH, superoxide anion radical
scavenging and iron-chelating activities.
DPPH (2,2-diphenyl-1-picrylhydrazyl) is a stable free
radical, in which electronic delocalization resulted in
deep violet coloration. Certain plant extracts are able to
donate hydrogen atoms and convert the DPPH radical
into its reduced and stable form, and hence resulted in
fading of violet color into pale yellow [45]. The in-vitro
DPPH radical scavenging assay was performed with
gallic acid as a positive control. Results revealed that all
plants were active (Table 2; Fig. 6).
Glycation reaction, and AGEs are known to produce re-
active oxygen intermediates (mainly superoxide anion and
hydrogen peroxide) both in-vitro as well as in-vivo. In the
in-vivo system, once generated, H2O2 can quickly enter
inside the cell, while other activated oxygen species can-
not. Within the cell, H2O2 can react with iron or copper
in the Fenton reaction, and leads to the formation of
hydroxyl radicals. These hydroxyl radicals contribute
factors in diabetes-related oxidative stress [46]. There-
fore metal chelators (e.g. Fe-chelators) can effectively
serve as AGE-inhibitors. Interestingly when we evaluated
the five active plants (i.e. S. cordifolia, P. zeylanica, T.
terrestris, G. glabra, and R. indica) for iron chelating
ability, all were found to be inactive, showing that
they do not have ability to chelate with the iron at
2 mg/mL concentration.
Superoxide radical anion is formed from the reduction
(i.e. one-electron) of free molecular oxygen by membrane-
bound enzyme i.e. nicotinamide adenine dinucleotide phos-
phate Oxidase (NADPH). Ortwerth et al. reported that in
glycation reaction, superoxide anion is formed by super-
oxide dismutase-dependent reduction of ferricytochrome
C. They reported that Amadori products (formed from the
reaction of lysine and small sugars) can generate superoxide
anion even in the absence of metals [47]. Therefore, scaven-
ging of superoxide anion was identifying as useful approach
to inhibit the glycation mediated complications. In the final
step of this study, we subjected all five plants for superoxide
anion radical scavenging assay. Results showed that except
G. glabra, all four plants scavenge the superoxide anion
radicals effectively (Table 2, Figs. 7, 8, 9, and 10).
Table 2 In-vitro antioxidant activity of medicinal plants of Arabian origin (which were found to be active in BSA-MG glycation assay)
Scientific Name DPPH radical scavenging activity Iron Chelation activity Superoxide anion radical scavenging activity
% RSAa IC50 ± SEM
b (mg/mL) % Chelationa % RSA IC50 ± SEM
b (mg/mL)
Glycyrrhiza glabra L. 82.99 0.237 ± 0.001 −9.50 5.00 –
Plumbago zeylanica L. 74.94 0.044 ± 0.001 −16.10 92.80 0.118 ± 0.004
Rosa indica L. 74.15 0.023 ± 0.0005 1.90 97.20 0.141 ± 0.003
Sida cordifolia L. 69.99 0.005 ± 0.0004 6.60 94.50 0.078 ± 0.002
Tribulus terrestris L. 79.69 0.157 ± 0.002 20.40 78.80 0.872 ± 0.011
Gallic acidb 93.13 0.004 ± 0.0004 – – –
EDTAc – – 99.10 – –
Quercetind – – – 99.80 0.0318 ± 0.001
a at 2 mg/mL concentration; IC50 Values are presented in mg/mL ± standard error of mean of three assays;









































Fig. 6 In-vitro antioxidant (DPPH) activity of medicinally important plants of Arabian origin which were found to be active against in-vitro
anti-glycation assay
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Fig. 7 In-vitro superoxide anion radical scavenging activity of methanolic extract of Sida cordifolia






















Fig. 8 In-vitro superoxide anion radical scavenging activity of methanolic extract of Plumbago zeylanica















Fig. 9 In-vitro superoxide anion radical scavenging activity of methanolic extract of Tribulus terrestris
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Conclusions
In conclusion, the crude methanolic extracts of Rosa
indica L., and Sida cordifolia L. have exhibited a potent
protein anti-glycation activity in in-vitro BSA-MG anti-
glycation model. On the basis of these findings, one of
the possible mechanisms of their reported antidiabetic
activities is the inhibition of glycation and antioxidant
properties. The anti-glycation activity of these medicinal
plants are in good agreement with their uses in antidia-
betic herbal medicines. Therefore, these plants needs to
be further investigated phytochemically as well as
pharmacologically to identify the active constituents and
to establish their therapeutic potential against glycation
induced pathologies in diabetes.
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